TABLE 3.
Group | VE mean ± SD | P‐value | VLP mean ± SD | P‐value | CEP mean ± SD | P‐value | CLP mean ± SD | P‐value |
---|---|---|---|---|---|---|---|---|
CO N = 10 | 0.81 ± 0.55 | 1.08 ± 0.44 | 1.20 ± 0.64 | 1.21 ± 0.33 | ||||
FRE N = 9 | 1.55 ± 0.81 | .01* | 1.67 ± 0.61 | .05* | 2.55 ± 0.73 | <.001*** | 1.85 ± 0.69 | .04* |
SRE N = 10 | 2.15 ± 0.77 | <.001** | 2.08 ± 0.81 | .009** | 2.36 ± 0.65 | <.001*** | 2.15 ± 0.58 | .03* |
PLE N = 9 | 2.08 ± 0.61 | .001** | 1.42 ± 0.31 | .37 | 2.56 ± 0.45 | <.001*** | 1.53 ± 0.38 | .79 |
Notes: Significant difference between groups *P < .05; ** P < .01; ***P < .001.
Abbreviations: CEP, crypt epithelium; CIE, chronic inflammatory enteropathy; CLP, crypt lamina propria; CO, control group; FRE, food responsive enteropathy; PLE, protein losing enteropathy; SRE, steroid responsive enteropathy; VE, villus epithelium; VLP, villus lamina propria.